Skip to Main Content U.S. Department of Energy
Economic Development Office

Tri-Cities Tech Business Update

December 2009 Issue

IsoRay to distribute technology in Canada


IsoRay, Inc., based in Richland, Wash., has signed a distribution agreement with Inter V Medical of Montreal, Quebec, Canada. Inter V Medical will have exclusive rights to sell IsoRay's cesium-131 brachytherapy seeds in Canada. Cesium-131 is currently used in the treatment of prostate cancer; head, neck, and lung cancer; and ocular melanoma. For nearly 20 years, Inter V Medical has brought new medical technologies, including brachytherapy and related products, to the Canadian market. Contact at 520-240-4840.

PNNL's EDO

News & Events

Programs & Resources

Share This

Share This!

Additional Information

Subscribe

Current Issue

Back Issues